Gaithersburg, MD, United States of America

Robert R Schultz

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert R Schultz. Retrieved from https://idiyas.com/inventor/robert-r-schultz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Robert R. Schultz: Innovator in Anti-Viral Pharmaceutical Compositions

Introduction

Robert R. Schultz is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-viral compositions. His work is recognized for its potential impact on public health and disease management.

Latest Patents

Robert R. Schultz holds 1 patent for his invention titled "Anti-viral pharmaceutical compositions containing saturated." This patent reflects his innovative approach to combating viral infections through advanced pharmaceutical formulations.

Career Highlights

Schultz is associated with the United States of America as represented by the Department of Health. His role in this esteemed organization underscores his commitment to advancing health solutions and contributing to the scientific community.

Collaborations

Throughout his career, Robert R. Schultz has collaborated with esteemed colleagues, including William G. Rice and David C. Baker. These partnerships have fostered a collaborative environment that enhances research and innovation in the pharmaceutical sector.

Conclusion

Robert R. Schultz's contributions to anti-viral pharmaceutical compositions highlight his dedication to improving health outcomes. His innovative work continues to inspire advancements in the field of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…